ECHAMP calls on the EU institutions to solve regulatory contradictions

ECHAMP has published its 2014 Annual Report, looking forward in 2015 to a fresh approach to the EU industry for homeopathic and anthroposophic medicinal products. 

The Annual Report demonstrates ECHAMP’s confidence that this sector can contribute viable, affordable and sustainable solutions to many of the health challenges faced by the EU. But it also shows that the legal and regulatory conditions for our sector are increasingly difficult, with decisions taken at European level in the name of harmonisation resulting in regulations that are partly non-practicable or do not add any value for these products. Substantial progress is still needed to ensure that these products can be and remain properly available in all Member States.

Calling for a new start, Gesine Klein, President of ECHAMP writes, “Homeopathic and anthroposophic medicines work. They help people, have few side effects, and are cost-effective and environmentally friendly. In 2015 and beyond, we will continue to work to safeguard and grow our sector. But we have to ask – when will the EU institutions acknowledge the challenges we face? It’s time to finally solve the regulatory contradictions in our sector.”